Neutrophil Extracellular Trap Formation in Advanced Heart Failure Patients-Preliminary Report

Tomasz Urbanowicz,Anna Olasińska-Wiśniewska,Ewelina Wojtasińska,Krzysztof J Filipiak,Małgorzata Tomaszewska,Jędrzej Sikora,Marta Krama,Zofia Radek,Kajetan Grodecki,Aleksandra Krasińska-Płachta,Beata Krasińska,Zbigniew Krasiński,Andrzej Tykarski,Marek Jemielity,Joanna Rupa-Matysek
DOI: https://doi.org/10.3390/ijms25179633
2024-09-05
Abstract:In end-stage heart failure, which is characterized by persistent or progressive ventricular dysfunction despite optimal medical therapy, a left ventricular assist device (LVAD) can be beneficial. Congestive heart failure provokes inflammatory and prothrombotic activation. The aim of this study was to evaluate the serum concentration of citrullinated histone 3 (CH3) representing neutrophil extracellular trap (NET) formation in patients referred for LVAD implantation. There were 10 patients with a median age of 61 (57-65) years enrolled in a prospective single-center analysis who underwent LVAD implantation. The CH3 plasma concentration was measured preoperatively and on the 1st and 7th postoperative days, followed by control measurements on the median (Q1-3) 88th (49-143) day. The preoperative CH3 concentration strongly correlated with brain natriuretic peptide (r = 0.879, p < 0.001). Significant differences in CH3 serum concentration were observed between pre- and postoperative measurements, including an increase on the first postoperative day (p < 0.001), as well as a decrease on the seventh day (p = 0.016) and in follow-up (p < 0.001). CH3 concentration, as a marker of NET formation, decreases after LVAD implantation.
What problem does this paper attempt to address?